{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:48:30Z","timestamp":1791402510096,"version":"4.3.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T00:00:00Z","timestamp":1263772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/nri2692","type":"journal-article","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T07:36:31Z","timestamp":1263800191000},"page":"103-110","source":"Crossref","is-referenced-by-count":876,"title":["Disease-associated functions of IL-33: the new kid in the IL-1 family"],"prefix":"10.1038","volume":"10","author":[{"given":"Foo Y.","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick I.","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,18]]},"reference":[{"key":"BFnri2692_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479\u2013490 (2005). This is the first report that identified IL-33.","journal-title":"Immunity"},{"key":"BFnri2692_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0014-5793(89)81679-5","volume":"258","author":"S Tominaga","year":"1989","unstructured":"Tominaga, S. A putative protein of a growth specific cDNA from BALB\/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 258, 301\u2013304 (1989). This is the first report of the identification of the orphan receptor ST2.","journal-title":"FEBS Lett."},{"key":"BFnri2692_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.187.5.787","volume":"187","author":"D Xu","year":"1998","unstructured":"Xu, D. et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187, 787\u2013794 (1998). This is the first demonstration of the selective and stable expression of ST2 on T H 2 but not T H 1 cells and encouraged the interest of ST2 in immunology.","journal-title":"J. Exp. Med."},{"key":"BFnri2692_CR4","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1073\/pnas.95.12.6930","volume":"95","author":"M Lohning","year":"1998","unstructured":"Lohning, M. et al. T1\/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl Acad. Sci. USA 95, 6930\u20136935 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1084\/jem.190.7.895","volume":"190","author":"AJ Coyle","year":"1999","unstructured":"Coyle, A. J. et al. Crucial role of the interleukin 1 receptor family member T1\/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 190, 895\u2013902 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnri2692_CR6","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada, S. et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 117, 1538\u20131549 (2007). This is the first report of a protective role of IL-33\u2013ST2 signalling in the cardiovascular system.","journal-title":"J. Clin. Invest."},{"key":"BFnri2692_CR7","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","volume":"3","author":"C Moussion","year":"2008","unstructured":"Moussion, C., Ortega, N. & Girard, J. P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One. 3, e3331 (2008).","journal-title":"PLoS One."},{"key":"BFnri2692_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20071868","volume":"205","author":"AM Miller","year":"2008","unstructured":"Miller, A. M. et al. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205, 339\u2013346 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnri2692_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl Acad. Sci. USA 104, 282\u2013287 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","volume":"163","author":"ES Baekkevold","year":"2003","unstructured":"Baekkevold, E. S. et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163, 69\u201379 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnri2692_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/embor.2008.145","volume":"9","author":"L Roussel","year":"2008","unstructured":"Roussel, L., Erard, M., Cayrol, C. & Girard, J. P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 9, 1006\u20131012 (2008).","journal-title":"EMBO Rep."},{"key":"BFnri2692_CR12","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl Acad. Sci. USA 106, 9021\u20139026 (2009). This paper reports that full length IL-33 is biologically active and can be released by cellular damage.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","volume":"31","author":"AU Luthi","year":"2009","unstructured":"Luthi, A. U. et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31, 84\u201398 (2009).","journal-title":"Immunity"},{"key":"BFnri2692_CR14","doi-asserted-by":"publisher","first-page":"19420","DOI":"10.1074\/jbc.M901744200","volume":"284","author":"D Talabot-Ayer","year":"2009","unstructured":"Talabot-Ayer, D., Lamacchia, C., Gabay, C. & Palmer, G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 284, 19420\u201319426 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnri2692_CR15","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1074\/mcp.M800132-MCP200","volume":"7","author":"M Lamkanfi","year":"2008","unstructured":"Lamkanfi, M. et al. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol. Cell. Proteomics 7, 2350\u20132363 (2008).","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnri2692_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbrc.2009.07.018","volume":"387","author":"M Hayakawa","year":"2009","unstructured":"Hayakawa, M. et al. Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. Biochem. Biophys. Res. Commun. 387, 218\u2013222 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri2692_CR17","doi-asserted-by":"crossref","first-page":"22100","DOI":"10.1016\/S0021-9258(20)80653-X","volume":"268","author":"JH Wessendorf","year":"1993","unstructured":"Wessendorf, J. H., Garfinkel, S., Zhan, X., Brown, S. & Maciag, T. Identification of a nuclear localization sequence within the structure of the human interleukin-1\u03b1 precursor. J. Biol. Chem. 268, 22100\u201322104 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnri2692_CR18","doi-asserted-by":"publisher","first-page":"8194","DOI":"10.4049\/jimmunol.181.12.8194","volume":"181","author":"T Eigenbrod","year":"2008","unstructured":"Eigenbrod, T., Park, J. H., Harder, J., Iwakura, Y. & Nunez, G. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1\u03b1 released from dying cells. J. Immunol. 181, 8194\u20138198 (2008).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ccr.2008.06.016","volume":"14","author":"T Sakurai","year":"2008","unstructured":"Sakurai, T. et al. Hepatocyte necrosis induced by oxidative stress and IL-1\u03b1 release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14, 156\u2013165 (2008).","journal-title":"Cancer Cell"},{"key":"BFnri2692_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2119\/2008-00034.Klune","volume":"14","author":"JR Klune","year":"2008","unstructured":"Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R. & Tsung, A. HMGB1: endogenous danger signaling. Mol. Med. 14, 476\u2013484 (2008).","journal-title":"Mol. Med."},{"key":"BFnri2692_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","volume":"29","author":"H Kazama","year":"2008","unstructured":"Kazama, H. et al. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29, 21\u201332 (2008).","journal-title":"Immunity"},{"key":"BFnri2692_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191\u2013195 (2002).","journal-title":"Nature"},{"key":"BFnri2692_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","volume":"17","author":"JJ Oppenheim","year":"2005","unstructured":"Oppenheim, J. J. & Yang, D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359\u2013365 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnri2692_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0306164","volume":"81","author":"ME Bianchi","year":"2007","unstructured":"Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1\u20135 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"BFnri2692_CR25","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1073\/pnas.0901206106","volume":"106","author":"PN Pushparaj","year":"2009","unstructured":"Pushparaj, P. N. et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl Acad. Sci. USA 106, 9773\u20139778 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR26","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","volume":"179","author":"AA Chackerian","year":"2007","unstructured":"Chackerian, A. A. et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551\u20132555 (2007). This report identifies IL-1RAP as a co-receptor for IL-33.","journal-title":"J. Immunol."},{"key":"BFnri2692_CR27","doi-asserted-by":"publisher","first-page":"18660","DOI":"10.1073\/pnas.0705939104","volume":"104","author":"S Ali","year":"2007","unstructured":"Ali, S. et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl Acad. Sci. USA 104, 18660\u201318665 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.cellsig.2008.05.013","volume":"20","author":"M Funakoshi-Tago","year":"2008","unstructured":"Funakoshi-Tago, M. et al. TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell. Signal. 20, 1679\u20131686 (2008).","journal-title":"Cell. Signal."},{"key":"BFnri2692_CR29","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","volume":"179","author":"Z Allakhverdi","year":"2007","unstructured":"Allakhverdi, Z., Smith, D. E., Comeau, M. R. & Delespesse, G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179, 2051\u20132054 (2007).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","volume":"40","author":"D Moulin","year":"2007","unstructured":"Moulin, D. et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40, 216\u2013225 (2007).","journal-title":"Cytokine"},{"key":"BFnri2692_CR31","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","volume":"181","author":"M Kurowska-Stolarska","year":"2008","unstructured":"Kurowska-Stolarska, M. et al. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181, 4780\u20134790 (2008).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend, W. P., Palmer, G. & Gabay, C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223, 20\u201338 (2008).","journal-title":"Immunol. Rev."},{"key":"BFnri2692_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/labinvest.3700663","volume":"87","author":"M Iikura","year":"2007","unstructured":"Iikura, M. et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87, 971\u2013978 (2007).","journal-title":"Lab. Invest."},{"key":"BFnri2692_CR34","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1189\/jlb.0407200","volume":"82","author":"LH Ho","year":"2007","unstructured":"Ho, L. H. et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE\u2013Fc\u025bRI signals. J. Leukoc. Biol. 82, 1481\u20131490 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"BFnri2692_CR35","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.M704916200","volume":"282","author":"H Hayakawa","year":"2007","unstructured":"Hayakawa, H., Hayakawa, M., Kume, A. & Tominaga, S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 282, 26369\u201326380 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnri2692_CR36","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/eji.200737547","volume":"37","author":"M Komai-Koma","year":"2007","unstructured":"Komai-Koma, M. et al. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37, 2779\u20132786 (2007).","journal-title":"Eur. J. Immunol."},{"key":"BFnri2692_CR37","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","volume":"20","author":"MD Smithgall","year":"2008","unstructured":"Smithgall, M. D. et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20, 1019\u20131030 (2008).","journal-title":"Int. Immunol."},{"key":"BFnri2692_CR38","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/eji.200838575","volume":"39","author":"E Bourgeois","year":"2009","unstructured":"Bourgeois, E. et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-\u03b3 production. Eur. J. Immunol. 39, 1046\u20131055 (2009).","journal-title":"Eur. J. Immunol."},{"key":"BFnri2692_CR39","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.4049\/jimmunol.181.9.5981","volume":"181","author":"M Suzukawa","year":"2008","unstructured":"Suzukawa, M. et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181, 5981\u20135989 (2008).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR40","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.4049\/jimmunol.0901575","volume":"183","author":"M Kurowska-Stolarska","year":"2009","unstructured":"Kurowska-Stolarska, M. et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183, 6469\u20136477 (2009).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR41","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","volume":"121","author":"WB Cherry","year":"2008","unstructured":"Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K. & Kita, H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121, 1484\u20131490 (2008).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnri2692_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/labinvest.2008.82","volume":"88","author":"M Suzukawa","year":"2008","unstructured":"Suzukawa, M. et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab. Invest. 88, 1245\u20131253 (2008).","journal-title":"Lab. Invest."},{"key":"BFnri2692_CR43","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.4049\/jimmunol.0803067","volume":"183","author":"Q Espinassous","year":"2009","unstructured":"Espinassous, Q. et al. IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J. Immunol. 183, 1446\u20131455 (2009).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","volume":"123","author":"MA Rank","year":"2009","unstructured":"Rank, M. A. et al. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 123, 1047\u20131054 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnri2692_CR45","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.4049\/jimmunol.180.4.2443","volume":"180","author":"NE Humphreys","year":"2008","unstructured":"Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y. & Grencis, R. K. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180, 2443\u20132449 (2008). The first direct demonstration that IL-33 is important in protecting mice against parasitic infection.","journal-title":"J. Immunol."},{"key":"BFnri2692_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1084\/jem.193.7.785","volume":"193","author":"G Walzl","year":"2001","unstructured":"Walzl, G. et al. Inhibition of T1\/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J. Exp. Med. 193, 785\u2013792 (2001). The first demonstration that ST2 signalling is important in controlling viral infection.","journal-title":"J. Exp. Med."},{"key":"BFnri2692_CR47","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","volume":"183","author":"D Prefontaine","year":"2009","unstructured":"Prefontaine, D. et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094\u20135103 (2009).","journal-title":"J. Immunol."},{"key":"BFnri2692_CR48","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1164\/rccm.200805-666OC","volume":"179","author":"J Kearley","year":"2009","unstructured":"Kearley, J., Buckland, K. F., Mathie, S. A. & Lloyd, C. M. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1\/ST2-IL-33 pathway. Am. J. Respir. Crit. Care Med. 179, 772\u2013781 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnri2692_CR49","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/intimm\/dxn037","volume":"20","author":"Y Kondo","year":"2008","unstructured":"Kondo, Y. et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20, 791\u2013800 (2008).","journal-title":"Int. Immunol."},{"key":"BFnri2692_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2009.06.008","volume":"386","author":"X Liu","year":"2009","unstructured":"Liu, X. et al. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem. Biophys. Res. Commun. 386, 181\u2013185 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri2692_CR51","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1084\/jem.190.10.1541","volume":"190","author":"K Hoshino","year":"1999","unstructured":"Hoshino, K. et al. The absence of interleukin 1 receptor-related T1\/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190, 1541\u20131548 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnri2692_CR52","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/eji.200636520","volume":"37","author":"NE Mangan","year":"2007","unstructured":"Mangan, N. E., Dasvarma, A., McKenzie, A. N. & Fallon, P. G. T1\/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur. J. Immunol. 37, 1302\u20131312 (2007).","journal-title":"Eur. J. Immunol."},{"key":"BFnri2692_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1165\/ajrcmb.12.4.7695919","volume":"12","author":"TT Kung","year":"1995","unstructured":"Kung, T. T. et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell. Mol. Biol. 12, 404\u2013409 (1995).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"BFnri2692_CR54","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","volume":"106","author":"EO Weinberg","year":"2002","unstructured":"Weinberg, E. O. et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106, 2961\u20132966 (2002).","journal-title":"Circulation"},{"key":"BFnri2692_CR55","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1161\/01.CIR.0000127958.21003.5A","volume":"109","author":"M Shimpo","year":"2004","unstructured":"Shimpo, M. et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109, 2186\u20132190 (2004).","journal-title":"Circulation"},{"key":"BFnri2692_CR56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","volume":"107","author":"EO Weinberg","year":"2003","unstructured":"Weinberg, E. O. et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107, 721\u2013726 (2003).","journal-title":"Circulation"},{"key":"BFnri2692_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1432-1033.2003.03377.x","volume":"270","author":"Y Haga","year":"2003","unstructured":"Haga, Y. et al. The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G. Eur. J. Biochem. 270, 163\u2013170 (2003).","journal-title":"Eur. J. Biochem."},{"key":"BFnri2692_CR58","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1189\/jlb.1207830","volume":"84","author":"CA Hudson","year":"2008","unstructured":"Hudson, C. A. et al. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 84, 631\u2013643 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnri2692_CR59","first-page":"327","volume":"113","author":"M Kanda","year":"2006","unstructured":"Kanda, M. et al. Elevation of ST2 protein levels in cerebrospinal fluid following subarachnoid hemorrhage. Acta Neurol. Scand. 113, 327\u2013333 (2006).","journal-title":"Acta Neurol. Scand."},{"key":"BFnri2692_CR60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/00004647-199911000-00013","volume":"19","author":"H Onda","year":"1999","unstructured":"Onda, H. et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 19, 1279\u20131288 (1999).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnri2692_CR61","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/mp.2009.10","volume":"14","author":"J Chapuis","year":"2009","unstructured":"Chapuis, J. et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry 14, 1004\u20131016 (2009).","journal-title":"Mol. Psychiatry"},{"key":"BFnri2692_CR62","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1073\/pnas.0712116105","volume":"105","author":"WA Verri Jr","year":"2008","unstructured":"Verri, W. A. Jr et al. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl Acad. Sci. USA 105, 2723\u20132728 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR63","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.1073\/pnas.0801898105","volume":"105","author":"D Xu","year":"2008","unstructured":"Xu, D. et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl Acad. Sci. USA 105, 10913\u201310918 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2692_CR64","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/art.24305","volume":"60","author":"G Palmer","year":"2009","unstructured":"Palmer, G. et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 60, 738\u2013749 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnri2692_CR65","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1128\/MCB.9.11.5207","volume":"9","author":"AK Werenskiold","year":"1989","unstructured":"Werenskiold, A. K., Hoffmann, S. & Klemenz, R. Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol. Cell. Biol. 9, 5207\u20135214 (1989).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri2692_CR66","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1006\/bbrc.2001.5306","volume":"285","author":"K Tago","year":"2001","unstructured":"Tago, K. et al. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem. Biophys. Res. Commun. 285, 1377\u20131383 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri2692_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-5793(93)81333-U","volume":"318","author":"K Yanagisawa","year":"1993","unstructured":"Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. & Tominaga, S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318, 83\u201387 (1993).","journal-title":"FEBS Lett."},{"key":"BFnri2692_CR68","first-page":"179","volume":"6","author":"E Thomassen","year":"1995","unstructured":"Thomassen, E. et al. Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue. Cell Growth Differ. 6, 179\u2013184 (1995).","journal-title":"Cell Growth Differ."},{"key":"BFnri2692_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4049\/jimmunol.173.1.145","volume":"173","author":"BP Leung","year":"2004","unstructured":"Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B. & Liew, F. Y. A novel therapy of murine collagen-induced arthritis with soluble T1\/ST2. J. Immunol. 173, 145\u2013150 (2004).","journal-title":"J. Immunol."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nri2692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nri2692","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nri2692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:26:00Z","timestamp":1684466760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri2692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,18]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFnri2692"],"URL":"https:\/\/doi.org\/10.1038\/nri2692","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,18]]}}}